Pulmonary embolism in children
Pulmonary embolism (PE) is a general term for a group of diseases or clinical syndromes caused by various emboli blocking the pulmonary artery system. In the past, it was believed that PE in children was rare in clinical practice, but a large amount of data and autopsies at home and abroad have confirmed that this disease is not a rare disease. The presence of high-risk factors for PE on the basis of the primary disease is the main cause of PE in children, such as congenital heart disease combined with infective endocarditis, nephrotic syndrome combined with hypercoagulable state, etc.
-
Site of disease:
lung -
Infectious :
Not contagious -
Frequent population:
Infants and young children -
Related symptoms:
Vascular murmur shortness of breath cyanosis dyspnea dyspnea -
Concurrent disease:
Related Drugs
Yangfei Pills
Manufacturer:
Tong Ren Tang Technologies Co., Ltd.
Lingyang Qingfei Granule
Manufacturer:
Jiangxi Baozhong Pharmaceutical Co., Ltd.
Acenocoumarol Tablets
Indication: It is used to prevent and treat intravascular thrombotic diseases, such as venous thrombosis, pulmonary embolism, myocardial infarction and embolism caused by atrial fibrillation. It is especially suitable for those who maintain long-term anticoagulation. For acute arterial occlusion, heparin should be used to control symptoms first, and then this product should be used.
Manufacturer:
Shanghai Sine Pharmaceutical Laboratories Co., Ltd.
Acenocoumarol Tablets
Indication: It is used to prevent and treat intravascular thrombotic diseases, such as venous thrombosis, pulmonary embolism, myocardial infarction and embolism caused by atrial fibrillation. It is especially suitable for those who maintain long-term anticoagulation. For acute arterial occlusion, heparin should be used to control symptoms first, and then this product should be used.
Manufacturer:
Shanghai Sine Pharmaceutical Laboratories Co., Ltd.
Related Ingredients
-
ACENOCOUMAROL list
152-72-7